These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 15259909)
1. Epstein-Barr virus load correlating with clinical manifestation and treatment response in a patient with angioimmunoblastic T-cell lymphoma. Battegay M; Berger C; Rochlitz C; Hurwitz N; Hirsch HH; De Geyter C; Haque T; Nadal D Antivir Ther; 2004 Jun; 9(3):453-9. PubMed ID: 15259909 [TBL] [Abstract][Full Text] [Related]
2. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Yang QX; Pei XJ; Tian XY; Li Y; Li Z Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632 [TBL] [Abstract][Full Text] [Related]
3. Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma. Skugor ND; Perić Z; Vrhovac R; Radić-Kristo D; Kardum-Skelin I; Jaksić B Coll Antropol; 2010 Mar; 34(1):241-5. PubMed ID: 20432757 [TBL] [Abstract][Full Text] [Related]
4. [Angioimmunoblastic lymphadenopathy and angioimmunoblastic T-cell lymphoma]. Li T; Gao D; Zhang B Zhonghua Bing Li Xue Za Zhi; 1996 Apr; 25(2):99-101. PubMed ID: 9206215 [TBL] [Abstract][Full Text] [Related]
5. EBV status has prognostic implication among young patients with angioimmunoblastic T-cell lymphoma. Eladl AE; Shimada K; Suzuki Y; Takahara T; Kato S; Kohno K; Elsayed AA; Wu CC; Tokunaga T; Kinoshita T; Sakata-Yanagimoto M; Nakamura S; Satou A Cancer Med; 2020 Jan; 9(2):678-688. PubMed ID: 31793218 [TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease. Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309 [TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi. Olson D; Gulley ML; Tang W; Wokocha C; Mechanic O; Hosseinipour M; Gold SH; Nguluwe N; Mwansambo C; Shores C Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):112-8. PubMed ID: 23260601 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Ohshima K; Takeo H; Kikuchi M; Kozuru M; Uike N; Masuda Y; Yoneda S; Takeshita M; Shibata T; Akamatsu M Histopathology; 1994 Dec; 25(6):569-79. PubMed ID: 7698734 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus clonality and plasmacytosis in a patient with atypical angioimmunoblastic T cell lymphoma. Okuyama S; Terada T; Kumagai H; Tsumanuma R; Omoto E; Ueki T; Yanagawa N; Maeda K; Tajima K Ann Hematol; 2018 Mar; 97(3):537-539. PubMed ID: 29189897 [No Abstract] [Full Text] [Related]
10. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma. Bräuninger A; Spieker T; Willenbrock K; Gaulard P; Wacker HH; Rajewsky K; Hansmann ML; Küppers R J Exp Med; 2001 Oct; 194(7):927-40. PubMed ID: 11581315 [TBL] [Abstract][Full Text] [Related]
11. In immunocompromised patients, Epstein-Barr virus lymphadenitis can mimic angioimmunoblastic T-cell lymphoma morphologically, immunophenotypically, and genetically: a case report and review of the literature. Steciuk MR; Massengill S; Banks PM Hum Pathol; 2012 Jan; 43(1):127-33. PubMed ID: 21733557 [TBL] [Abstract][Full Text] [Related]